Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine

被引：0

作者：

Marghalani, Siham ^{[1
]}

Alghamdi, Yara ^{[2
,3
]}

Albrakati, Bakr A. ^{[4
]}

Huwait, Hassan F. ^{[5
]}

Mohanna, Abdulrahman T. ^{[2
]}

机构：

[1] King Abdulaziz Med City KAMC, Dermatol, Jeddah, Saudi Arabia

[2] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia

[3] Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia

[4] Hera Gen Hosp, Dermatol, Mecca, Saudi Arabia

[5] Umm Al Qura Univ, Dermatopathol, Jeddah, Saudi Arabia

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2024年 / 16卷 / 03期

关键词：

drug-related side effects and adverse reactions; pfizer-biontech bnt162b2; pfizer-biontech covid-19 vaccine; astra zeneca covid-19 vaccine; oxford-astrazeneca vaccine; pityriasis rosea;

D O I：

10.7759/cureus.56310

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The coronavirus disease 2019 (COVID-19) infection has led to accelerated development and utilization of vaccines to prevent its implications on health. One of these vaccines is a vector -based, Oxford-AstraZeneca Vaccine (AZD1222). Frequently reported side effects are related to host -immune response. While dermatologic manifestation is peculiar in nature and denotes a serious eruption that might defer future vaccination. Herein, we present a case of a medically free 37 -year -old female who developed clinical and histological evidence of pityriasis rosea (PR) after administration of a second -dose vaccination of AZD1222. The first dose of vaccination was administered as Pfizer BioNTech COVID-19 mRNA (BNT162b2) vaccine. This case is unique in nature as this patient developed AZD1222-induced PR, while some reports in the literature have linked PR to the BNT162b2 vaccine. This patient continued to receive a booster vaccination with BNT162b2 with no reportable side effects.

引用

页数：5

共 14 条

[1] Pityriasis rosea after mRNA COVID-19 vaccination [J].

Abdullah, Lina ;

Hasbani, Divina ;

Kurban, Mazen ;

Abbas, Ossama .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) :1150-1151

[2] Atypical pityriasis rosea associated with mRNA COVID-19 vaccine [J].

Bostan, Ecem ;

Jarbou, Adam .

JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) :814-816

[3] Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases [J].

Catala, A. ;

Munoz-Santos, C. ;

Galvan-Casas, C. ;

Roncero Riesco, M. ;

Revilla Nebreda, D. ;

Sola-Truyols, A. ;

Giavedoni, P. ;

Llamas-Velasco, M. ;

Gonzalez-Cruz, C. ;

Cubiro, X. ;

Ruiz-Villaverde, R. ;

Gomez-Armayones, S. ;

Gil Mateo, M. P. ;

Pesque, D. ;

Marcantonio, O. ;

Fernandez-Nieto, D. ;

Romani, J. ;

Iglesias Pena, N. ;

Carnero Gonzalez, L. ;

Tercedor-Sanchez, J. ;

Carretero, G. ;

Masat-Tico, T. ;

Rodriguez-Jimenez, P. ;

Gimenez-Arnau, A. M. ;

Utrera-Busquets, M. ;

Vargas Laguna, E. ;

Angulo Menendez, A. G. ;

San Juan Lasser, E. ;

Iglesias-Sancho, M. ;

Alonso Naranjo, L. ;

Hiltun, I ;

Cutillas Marco, E. ;

Polimon Olabarrieta, I ;

Marinero Escobedo, S. ;

Garcia-Navarro, X. ;

Calderon Gutierrez, M. J. ;

Baeza-Hernandez, G. ;

Bou Camps, L. ;

Toledo-Pastrana, T. ;

Guilabert, A. .

BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) :142-152

[4] Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine [J].

Cohen, Olivia G. ;

Clark, Ashley K. ;

Milbar, Heather ;

Tarlow, Mordechai .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) :4097-4098

[5] Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine [J].

Cyrenne, B. M. ;

Al-Mohammedi, F. ;

DeKoven, J. G. ;

Alhusayen, R. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) :E546-E548

[6]

Dormann Harald, 2021, Dtsch Arztebl Int, V118, P431, DOI 10.3238/arztebl.m2021.0257

[7] Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination [J].

Leerunyakul, Kanchana ;

Pakornphadungsit, Kallapan ;

Suchonwanit, Poonkiat .

FRONTIERS IN MEDICINE, 2021, 8

[8] Pityriasis rosea developing after COVID-19 vaccination [J].

Marcantonio-Santa Cruz, O. Y. ;

Vidal-Navarro, A. ;

Pesque, D. ;

Gimenez-Arnau, A. M. ;

Pujol, R. M. ;

Martin-Ezquerra, G. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (11) :E721-E722

[9] Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study [J].

McMahon, Devon E. ;

Kovarik, Carrie L. ;

Damsky, William ;

Rosenbach, Misha ;

Lipoff, Jules B. ;

Tyagi, Anisha ;

Chamberlin, Grace ;

Fathy, Ramie ;

Nazarian, Rosalynn M. ;

Desai, Seemal R. ;

Lim, Henry W. ;

Thiers, Bruce H. ;

Hruza, George J. ;

French, Lars E. ;

Blumenthal, Kimberly ;

Fox, Lindy P. ;

Freeman, Esther E. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) :113-121

[10] Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification [J].

Kaundinya, Trisha ;

Kundu, Roopal V. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) :E53-E54

← 1 2 →